Expert Guide to Transcatheter Heart Valve Replacement and Cardiac Surgery Centers

A diagnosis of serious heart valve disease can quickly lead to unfamiliar terms:

TAVR. TAVI. SAVR. Valve repair. Tissue valve. Mechanical valve. TEER. Structural heart disease.

For patients and families, the technology can make the decision seem simple:

“Can the valve be replaced without open-heart surgery?”

But the best heart valve treatment is not determined by incision size alone.

Modern valve treatment can include catheter-based procedures, minimally invasive surgery and conventional cardiac surgery. The right choice depends on the valve involved, severity of disease, symptoms, anatomy, age, life expectancy, other heart conditions, previous procedures and the expected durability of the treatment.

The American Heart Association describes transcatheter aortic valve replacement (TAVR), also called TAVI, as a minimally invasive procedure in which a new valve is placed inside the diseased aortic valve without removing it.

The 2025 ESC/EACTS guidelines on valvular heart disease emphasize contemporary diagnosis and individualized treatment selection rather than treating every valve problem with one procedure.

For patients comparing cardiac surgery centers, the better question is therefore not:

“Which hospital performs TAVR?”

It is:

“Which center can evaluate all reasonable valve-treatment options and recommend the best one for my specific anatomy and long-term needs?”

This guide explains TAVR/TAVI, surgical valve replacement, emerging mitral and tricuspid interventions, the Heart Team model, hospital selection, complications, recovery, insurance and total treatment cost.

What Is Heart Valve Disease?

The heart contains four major valves:

Aortic

Mitral

Tricuspid

Pulmonary

These valves help blood move through the heart in the correct direction.

Two major problems can develop.

Stenosis

The valve becomes narrowed and cannot open properly.

This makes it harder for blood to move forward.

Regurgitation

The valve does not close properly and blood leaks backward.

The heart may gradually need to work harder to compensate.

The seriousness of either condition depends on the valve involved and the severity of dysfunction.

What Is Aortic Stenosis?

Aortic stenosis is narrowing of the valve between the heart’s left ventricle and the aorta.

When severe, it can restrict blood flow from the heart to the body.

Possible symptoms include:

Shortness of breath
Chest discomfort
Fatigue
Reduced exercise tolerance
Dizziness
Fainting

Not every patient has obvious symptoms, which is one reason regular cardiac evaluation matters when significant valve disease is identified.

The American Heart Association currently describes TAVI/TAVR as one treatment used for serious aortic stenosis, with catheter delivery commonly performed through an artery.

What Is TAVR or TAVI?

TAVR means:

Transcatheter Aortic Valve Replacement

TAVI means:

Transcatheter Aortic Valve Implantation

The terms are commonly used for the same general procedure.

During TAVR, a replacement tissue valve is compressed onto a catheter and guided to the heart.

When positioned correctly, the new valve is expanded inside the diseased native aortic valve.

The old valve is generally not surgically removed.

The new valve takes over blood-flow regulation.

The NIH’s National Heart, Lung, and Blood Institute describes TAVR as a minimally invasive procedure using an animal-tissue replacement valve and notes that it does not require conventional open-heart surgery.

How Is TAVR Performed?

The most common route is transfemoral TAVR.

A catheter enters through an artery in the groin and is guided toward the heart.

Other access routes may sometimes be required when the femoral arteries are unsuitable.

The patient may receive sedation or general anesthesia depending on the center and clinical circumstances.

AHA notes that many patients can leave the hospital within a few days, although length of stay depends on age, health and complications.

Modern programs increasingly use streamlined or “minimalist” pathways in selected patients. ESC reported in 2025 that minimalist TAVI approaches have become widely adopted in Europe and that a randomized trial found a minimalist strategy noninferior to a more standard approach for the tested 30-day composite outcome.

That does not mean every patient should receive minimal sedation or same-day-type care.

Patient selection remains important.

Who May Be Considered for TAVR?

TAVR was originally used primarily for patients who could not safely undergo conventional surgery or who faced high operative risk.

Its use has expanded substantially.

The AHA now states that TAVR is available across surgical-risk categories.

However, “available” does not mean “best for everyone.”

The Heart Team may consider:

Age

Life expectancy

Surgical risk

Aortic anatomy

Coronary arteries

Previous heart surgery

Other valve disease

Need for bypass surgery

Expected valve durability

Patient preferences

A younger patient with decades of expected life may face a different lifetime valve-management decision from an older patient whose priority is avoiding major surgery.

What Is SAVR?

SAVR stands for:

Surgical Aortic Valve Replacement.

During surgical replacement, the diseased aortic valve is surgically removed and replaced with a prosthetic valve.

This generally involves cardiac surgery and often cardiopulmonary bypass.

Surgical valves may include:

Mechanical valves

Biologic/tissue valves.

The American Heart Association lists mechanical and tissue prostheses among major heart-valve replacement options.

TAVR vs Surgical Aortic Valve Replacement

This is one of the most important decisions in structural heart care.

TAVR can offer a less invasive approach and often faster early recovery.

Surgical valve replacement may provide advantages in other situations.

For example, SAVR may be particularly relevant when a patient also needs:

Coronary bypass surgery
Another valve operation
Aortic surgery
Certain complex anatomic corrections

Long-term valve strategy can also matter.

A 2025 five-year analysis summarized by the American College of Cardiology found TAVR noninferior to surgery for the trial’s low-risk population, while also showing different tradeoffs: TAVR had lower valve gradients, whereas surgery had fewer new pacemakers and less mild paravalvular regurgitation.

This illustrates an important principle:

TAVR and surgery do not have identical strengths and complications.

The decision is not simply “less invasive = better.”

Why the Heart Team Matters

High-quality valve programs often use a multidisciplinary Heart Team.

This may include:

Interventional cardiologist
Cardiac surgeon
Imaging cardiologist
Cardiac anesthesiologist
Heart-failure specialist
Structural heart coordinator
Other specialists where appropriate

The value of this approach is that a patient should ideally receive a treatment recommendation based on the disease—not based on whichever specialist they happened to meet first.

A surgeon may be able to explain SAVR.

An interventional cardiologist may explain TAVR.

The best center can compare both.

Pre-TAVR Evaluation

TAVR requires detailed planning.

A typical assessment may include:

Echocardiography

This evaluates:

Valve narrowing
Valve leakage
Heart pumping function
Other valves
Pressure changes

CT Imaging

CT can be crucial for evaluating:

Aortic annulus size
Valve anatomy
Calcium
Coronary artery location
Vascular access

Correct device sizing is a major part of procedural planning.

Coronary Evaluation

Some patients may require evaluation for coronary artery disease.

This can influence whether catheter-based treatment or surgery makes more sense.

Blood Tests and General Assessment

Kidney function, anemia, infection risk and other medical conditions may affect procedural planning.

Risks of TAVR

TAVR is less invasive than open-heart surgery, but it is not risk-free.

Potential complications can include:

Bleeding
Blood-vessel injury
Stroke
Heart attack
Kidney injury
Valve leakage
Infection
Arrhythmias
Need for permanent pacemaker
Emergency surgery
Death

Different devices and anatomies can carry different risk profiles.

Patients should ask for individualized risks rather than relying on a generic online percentage.

Pacemaker Risk

One issue particularly relevant to TAVR is the possibility that the procedure affects the heart’s electrical conduction system.

Some patients therefore need a permanent pacemaker after treatment.

The likelihood depends on:

Valve type
Patient conduction system
Anatomy
Implant depth
Other factors

The five-year Evolut Low Risk comparison cited by ACC found new pacemaker placement lower in the surgical group than in the TAVR group, highlighting this tradeoff.

Paravalvular Leak

A transcatheter valve sits within the original calcified valve.

In some patients, blood can leak around the outside of the replacement valve.

This is called:

paravalvular regurgitation or paravalvular leak.

Modern devices have been designed to reduce this problem, but it has not disappeared completely.

The importance depends on severity.

Stroke Risk

Stroke is one of the most serious potential complications of heart valve procedures.

Material can potentially travel through the bloodstream during intervention.

Patients should discuss:

Their baseline stroke risk
Procedure-related stroke risk
Whether the center uses cerebral protection in selected cases
The evidence supporting any additional device being proposed

A technology should not be added solely because it sounds advanced.

Valve Durability

Durability matters particularly for younger patients.

A valve that works extremely well today also needs to fit into the patient’s lifetime treatment strategy.

Questions include:

How long is this valve expected to function?

What happens if it degenerates?

Could I have valve-in-valve TAVR later?

Will the first valve make future coronary access difficult?

Could future surgery be necessary?

These questions may be more important than hospital stay length when a patient is relatively young.

Valve-in-Valve TAVR

Some patients have a previously implanted surgical tissue valve that eventually fails.

In selected cases, a transcatheter valve can be placed inside the failing surgical valve.

This is called:

valve-in-valve TAVR.

FDA approvals have expanded transcatheter-valve applications into certain failing surgical bioprosthetic valves, including specified mitral-valve scenarios for patients at increased surgical risk.

Suitability depends heavily on anatomy and the original prosthesis.

Aortic Regurgitation and TAVR

TAVR is most established for aortic stenosis.

Pure aortic regurgitation creates different technical challenges because the valve may lack the calcification that helps some TAVR devices anchor.

ACC noted in 2025 that conventional TAVR valves designed for aortic stenosis do not work optimally in pure aortic regurgitation, while dedicated transcatheter systems are being developed and studied.

Therefore, patients with aortic regurgitation should not assume that information about TAVR for aortic stenosis applies directly to them.

Mitral Valve Disease

The mitral valve is between the left atrium and left ventricle.

Major problems include:

Mitral regurgitation

and

Mitral stenosis.

Treatment can include surgical repair, surgical replacement or selected transcatheter procedures.

Repair is often preferred over replacement in appropriate forms of degenerative mitral regurgitation when a durable repair is achievable at an experienced center.

What Is TEER?

TEER means:

Transcatheter Edge-to-Edge Repair.

It is a catheter-based technique used in selected patients with mitral regurgitation.

Rather than replacing the entire valve, the procedure brings portions of the mitral leaflets together to reduce leakage.

Commercial systems such as MitraClip are used in selected primary and secondary mitral regurgitation populations according to applicable indications and guidelines.

TEER is not appropriate for every leaking mitral valve.

A center should be able to compare:

TEER vs surgical repair vs surgical replacement vs medical therapy

depending on anatomy and patient condition.

Transcatheter Mitral Valve Replacement

Transcatheter mitral valve replacement is a developing area.

Certain transcatheter valves already have regulatory approval for specific situations such as selected failing surgical tissue valves.

For example, FDA information describes SAPIEN 3-family transcatheter valves for selected patients with failing tissue mitral valves who face increased risk from open surgery.

Native mitral-valve replacement through a catheter remains more technically challenging than TAVR because mitral anatomy is complex.

Patients should distinguish approved standard indications from clinical-trial use.

Tricuspid Valve Disease

The tricuspid valve sits on the right side of the heart.

Severe tricuspid regurgitation can cause:

Swelling
Abdominal fluid
Fatigue
Liver congestion
Reduced exercise capacity

Transcatheter tricuspid repair and replacement technologies are an evolving part of structural heart medicine.

Because availability and approvals differ significantly by country, patients should verify whether a proposed device is:

approved

off-label

investigational.

What Defines a Leading Heart Valve Center?

The best center is not simply the one performing the most TAVR procedures.

Look for several capabilities working together.

High-Volume Structural Heart Team

Ask how many procedures the team performs, particularly for cases similar to yours.

Cardiac Surgery Backup

Even primarily catheter-based programs should have strong cardiac surgical expertise.

Advanced Imaging

High-quality:

Echocardiography
CT
Transesophageal echo
Cardiac catheterization imaging

can directly affect patient selection and planning.

Multiple Treatment Options

A strong center should not offer only one valve technology.

It should be able to evaluate:

TAVR
SAVR
Surgical repair
Minimally invasive surgery
TEER
Valve-in-valve procedures
Clinical trials

where relevant.

Emergency Support

Ask whether:

Cardiac surgery
ICU
Vascular surgery
Advanced imaging
Electrophysiology

are immediately available if complications occur.

Hospital Volume vs Individual Operator Experience

Hospital experience matters.

But so does the physician performing the procedure.

Ask:

How many TAVR procedures have you performed?

How frequently do you treat patients with my anatomy?

What are your stroke, pacemaker and vascular-complication rates?

How often do your patients need emergency surgery?

Do you track 30-day and one-year outcomes?

The answers may be more informative than a national ranking.

Recovery After TAVR

Because TAVR does not usually require sternotomy, recovery can be relatively fast in uncomplicated cases.

AHA notes that many patients leave the hospital within a few days.

Patients may need instructions about:

Access-site care
Walking
Medications
Driving
Physical activity
Warning symptoms
Follow-up imaging

The exact recovery period depends on age, frailty and complications.

Recovery After Surgical Valve Replacement

Recovery after open cardiac surgery is generally longer.

The American Heart Association states that typical heart-valve surgery recovery may take approximately four to eight weeks, though recovery can be shorter after minimally invasive procedures.

Sternotomy healing, physical conditioning and cardiac rehabilitation can influence recovery time.

Cardiac Rehabilitation

Cardiac rehabilitation can help selected patients safely rebuild activity after valve procedures.

It may include:

Monitored exercise
Cardiovascular education
Risk-factor management
Nutrition support
Lifestyle counselling

Ask whether the heart center provides or refers patients to cardiac rehabilitation.

TAVR Cost: Why There Is No Universal Price

Heart valve treatment costs vary dramatically between countries, hospitals and insurance systems.

A complete TAVR bill may include:

Cardiologist/procedural fee

Replacement valve/device

Hospital facility charges

Catheterization laboratory or hybrid operating room

CT imaging

Echocardiography

Anesthesia

Laboratory testing

Hospital stay

Medications

Follow-up

and, if complications occur:

Pacemaker, ICU care or additional procedures.

This means an advertised “TAVR price” may not represent the total episode of care.

TAVR vs Surgery Cost

TAVR can potentially reduce certain costs associated with prolonged hospitalization and surgical recovery.

But the transcatheter valve itself can be expensive.

Surgery has its own major costs:

Operating room
Cardiopulmonary bypass
Surgical team
ICU stay
Longer recovery

Which approach costs more varies by healthcare system, complications and individual case.

Cost should therefore follow—not drive—the clinical decision when both treatments are not medically equivalent.

Request an Itemized Estimate

Before an elective procedure, ask the hospital for a written estimate.

Clarify whether it includes:

Valve/device cost

Physician fees

Imaging

Anesthesia

Hospital stay

ICU

Pacemaker if needed

Follow-up

and

Potential complication-related costs.

International patients should also request information about deposits and refund terms.

Insurance Coverage

Insurance rules differ dramatically between health systems.

Before treatment, verify:

Is the hospital in-network?

Is the cardiologist in-network?

Is the cardiac surgeon in-network?

Is TAVR medically covered under my plan?

Is prior authorization required?

What deductible remains?

What copayment or coinsurance applies?

What is my expected out-of-pocket amount?

A verbal statement that “TAVR is covered” is not enough.

Ask for an estimate of your personal responsibility.

Prior Authorization

Major structural-heart procedures commonly require detailed clinical documentation.

The hospital may need to submit:

Echocardiogram findings
Valve severity
Symptoms
CT results
Heart Team assessment
Surgical-risk information

to the payer depending on the insurance system.

Authorization should ideally be confirmed before an elective procedure.

In-Network vs Out-of-Network Treatment

In insurance-based systems, network status can materially change out-of-pocket costs.

Do not verify only the hospital.

Confirm the professional teams involved, which may include:

Interventional cardiologist
Cardiac surgeon
Anesthesiologist
Imaging physician

depending on the billing system.

International Patients and Medical Travel

Patients sometimes travel internationally for TAVR or advanced valve surgery because of:

Specialist expertise
Reduced wait times
Cost differences
Access to particular technology
Second opinions

International treatment adds additional considerations:

Flights

Accommodation

Visa

Caregiver travel

Post-procedure stay

Emergency care

Follow-up after returning home

Ask the center how long you should remain locally before flying.

Second Opinions

A second opinion can be particularly valuable when:

TAVR and surgery are both reasonable
You are relatively young
More than one valve needs treatment
You also need coronary bypass surgery
Anatomy is complex
A transcatheter procedure is investigational
The first recommendation carries major lifetime implications

For a long-term valve decision, an additional Heart Team review can help clarify tradeoffs.

Red Flags When Choosing a Valve Center

Avoid hospitals or marketing agents claiming:

“TAVR is always better than open surgery.”

“Zero stroke risk.”

“No complications.”

“This valve will last forever.”

“You can definitely go home tomorrow.”

“Everyone is eligible for catheter valve replacement.”

Every valve intervention creates its own short- and long-term considerations. ACC has emphasized that treating valve disease replaces the original valve problem with a new set of prosthesis-related and follow-up considerations.

Questions to Ask Before TAVR or Valve Surgery

Ask your Heart Team:

Which valve is diseased?
How severe is the problem?
Do I need treatment now?
Am I a candidate for TAVR/TAVI?
Is surgery also appropriate?
Why do you recommend one over the other?
What are my individualized stroke and pacemaker risks?
How long is the proposed valve expected to last?
What happens if this valve fails later?
Will this treatment affect future coronary procedures?
Do I need bypass surgery or another valve treated?
What is the expected hospital stay?
What is my expected recovery?
What is the total estimated cost?
What portion is expected to be covered by insurance?
Should I obtain a second Heart Team opinion?

TAVR Is Not the Same as Minimally Invasive Heart Surgery

These terms are sometimes confused.

TAVR is catheter-based valve replacement.

Minimally invasive surgical valve replacement still involves surgery but may use smaller chest incisions than conventional sternotomy.

Each approach has different indications and risks.

Do not assume “minimally invasive” always means transcatheter.

Mechanical vs Tissue Valves

Patients undergoing surgery may need to choose between valve types.

Mechanical Valve

Potential advantage:

Long durability.

Major consideration:

Long-term anticoagulation is commonly required.

Tissue Valve

Potential advantage:

Long-term anticoagulation requirements may differ from mechanical valves.

Major consideration:

Biologic valves can deteriorate over time.

Age, lifestyle, pregnancy considerations, bleeding risk and potential future valve-in-valve treatment can all affect the decision.

This should be an individualized discussion.

What About Asymptomatic Severe Aortic Stenosis?

Historically, many patients without symptoms were monitored until traditional treatment triggers emerged.

This area is evolving.

ACC summarized the EARLY TAVR trial showing benefit of early TAVR versus surveillance in selected patients with asymptomatic severe aortic stenosis, and FDA subsequently expanded approvals for certain transcatheter valves in this setting in 2025.

However, this does not mean every asymptomatic patient should automatically undergo TAVR.

Current guideline-based evaluation, ventricular function, exercise testing and individual risk remain important.

Final Verdict: How Should You Choose a Heart Valve Center?

TAVR/TAVI has transformed the treatment of aortic valve disease.

A procedure that once required open-heart surgery in almost every patient can now be performed through a catheter in many appropriately selected cases.

But the success of modern structural heart care is not simply the result of a valve device.

It depends on:

Diagnosis

→ Advanced imaging

→ Heart Team evaluation

→ Correct procedure selection

→ Experienced intervention or surgery

→ Complication management

→ Long-term follow-up.

For an older patient with severe aortic stenosis and suitable anatomy, TAVR may provide a compelling less-invasive treatment.

For a younger patient needing decades of valve durability—or a patient who also requires bypass or complex aortic surgery—surgical replacement may be the stronger strategy.

For mitral or tricuspid disease, the comparison may involve repair, replacement, catheter-based interventions or clinical trials rather than TAVR.

The best cardiac center therefore is not the one that performs the most aggressively advertised procedure.

It is the one capable of saying:

“TAVR is right for you.”

or, just as importantly,

“Surgery is the better option.”

Patients should prioritize:

Heart Team expertise + case volume + imaging + surgical backup + outcomes + long-term planning + transparent costs

over hospital marketing.

Frequently Asked Questions

What is TAVR?

TAVR is a catheter-based procedure used to replace a diseased aortic valve without surgically removing the original valve. A new tissue valve is expanded inside it.

Are TAVR and TAVI the same?

Yes. TAVR means transcatheter aortic valve replacement, while TAVI means transcatheter aortic valve implantation. The terms generally refer to the same procedure.

Is TAVR open-heart surgery?

No. TAVR is catheter-based and does not require conventional open-heart surgery.

Is TAVR better than surgical valve replacement?

Not universally. Patient age, anatomy, surgical risk, other heart disease, valve durability and future procedures influence the decision. Five-year low-risk trial data show different advantages and complications between the two approaches.

Can low-risk patients receive TAVR?

Yes, TAVR has expanded beyond high-risk populations. AHA currently notes that it is available across risk categories, though individual suitability still requires evaluation.

What is the most common TAVR access route?

Transfemoral access through an artery in the groin is commonly used when anatomy allows.

How long do patients stay in hospital after TAVR?

Many patients can go home within a few days, but hospital stay varies according to health, age and complications.

How long is recovery after open valve surgery?

AHA says typical recovery after heart-valve surgery is approximately four to eight weeks and may be shorter after minimally invasive approaches.

Can TAVR cause a stroke?

Stroke is a recognized serious complication of TAVR and other cardiac interventions. Individual risk should be discussed with the treating Heart Team.

Can TAVR require a pacemaker?

Yes. Some patients develop conduction problems after TAVR and require permanent pacemaker implantation. Five-year comparative low-risk data showed greater new pacemaker use with TAVR than surgery in that particular trial.

What is valve-in-valve TAVR?

It is placement of a transcatheter valve inside a failing previously implanted tissue valve in selected patients.

Can TAVR treat aortic regurgitation?

TAVR is most established for aortic stenosis. Pure aortic regurgitation is technically different, and dedicated transcatheter devices are still an evolving area.

What is TEER?

Transcatheter edge-to-edge repair is a catheter-based procedure that brings portions of a leaking mitral valve together to reduce regurgitation in appropriately selected patients.

Can a mitral valve be replaced by catheter?

Selected failing surgical tissue mitral valves can be treated with approved transcatheter valve systems in certain higher-risk patients. Native transcatheter mitral valve replacement remains a more complex and evolving field.

How much does TAVR cost?

There is no universal price. Costs vary by country, hospital, valve device, hospital stay, physician charges, imaging, insurance and complications.

Does insurance cover TAVR?

Coverage varies by health system and policy. Patients should verify medical-necessity requirements, authorization, network status, deductible, copay/coinsurance and expected out-of-pocket responsibility before treatment.

Should I get a second opinion before TAVR?

A second Heart Team opinion can be especially valuable when both surgery and TAVR are viable, the patient is relatively young, anatomy is complex or multiple heart procedures may be required.

How should I choose a TAVR hospital?

Look for an experienced multidisciplinary structural-heart program with advanced imaging, cardiac surgery backup, ICU support, transparent outcome monitoring and the ability to offer both catheter-based and surgical options.

Does the newest valve device guarantee better results?

No. Device selection should match anatomy and clinical needs. Newer technology does not automatically provide superior outcomes for every patient.

Medical & Financial Disclaimer

This article is for general educational information only and does not recommend TAVR, surgery, a specific valve device or a particular hospital.

Heart valve treatment should be individualized after evaluation by qualified cardiology and cardiac-surgery specialists.

TAVR, SAVR, mitral procedures and other valve interventions can cause serious complications, including stroke, bleeding, vascular injury, pacemaker requirement and death.

Medical-device approvals, clinical guidelines, insurance coverage and procedure availability vary by country and can change.

Before treatment, obtain individualized information about:

diagnosis + treatment alternatives + procedure risks + valve durability + hospital experience + expected recovery + total cost + insurance authorization + long-term follow-up.